25 studies found for:    INFLAMMATORY BOWEL DISEASE 12
Show Display Options
Rank Status Study
1 Enrolling by invitation A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo;   Drug: Ustekinumab
2 Completed Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: mesalamine;   Drug: ALTH12-1:4;   Drug: ALTH12-2:4
3 Completed
Has Results
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol 400 mg
4 Not yet recruiting Cyclic Exclusive Enteral Nutrition as Maintenance Therapy for Pediatric Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: MODULEN IBD
5 Completed
Has Results
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Ustekinumab 90 mg;   Drug: Ustekinumab 4.5 mg/kg;   Drug: Placebo SC;   Drug: Placebo IV
6 Completed Monoclonal Antibody Treatment of Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: J695
7 Active, not recruiting Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Condition: Crohn's Disease
Interventions: Biological: Trichuris suis ova (TSO);   Biological: Placebo
8 Recruiting IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
9 Terminated
Has Results
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Asacol 400 mg
10 Recruiting The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: VSL#3
11 Completed Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326 mesylate
12 Completed The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326
13 Terminated The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
Condition: Crohn's Disease
Intervention: Drug: Mesalazine (Mesalamine)
14 Completed Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: STA-5326 mesylate
15 Completed (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.
Condition: Ulcerative Colitis
Interventions: Drug: Budesonide MMX 6 mg Tablet;   Drug: Placebo Tablet
16 Active, not recruiting A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: VB-201 160mg;   Drug: Placebo
17 Terminated A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
Condition: Ulcerative Colitis
Intervention: Drug: mesalamine
18 Completed The Colitis Once Daily Asacol Study
Condition: Ulcerative Colitis
Intervention: Drug: mesalazine (Asacol®)
19 Completed Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: SPD476 (mesalazine)
20 Completed
Has Results
A Comparison of Once a Day Dose Compared to 2 Doses/Day
Condition: Ulcerative Colitis
Interventions: Drug: Mesalamine Once-Daily;   Drug: Mesalamine Twice-Daily

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years